CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy


Yildirim F. E. , KARADUMAN A. , PINAR A. , AKSOY Y.

INTERNATIONAL JOURNAL OF DERMATOLOGY, vol.50, no.8, pp.948-955, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 8
  • Publication Date: 2011
  • Doi Number: 10.1111/j.1365-4632.2010.04799.x
  • Title of Journal : INTERNATIONAL JOURNAL OF DERMATOLOGY
  • Page Numbers: pp.948-955

Abstract

Objective The aim of this study is to determine serum levels of soluble forms of CD26/dipeptidyl-peptidase IV (DPP-IV) and adenosine deaminase (ADA), thought to be markers of T-cell activation, and changes in their levels in response to cyclosporine, etanercept, and psoralen plus ultraviolet A (PUVA) treatments with respect to disease activity.